Bültmann & Gerriets
Introduction to Analysis of Variance
Design, Analyis & Interpretation
von J. Rick Turner, Julian F. Thayer, David Turner
Verlag: Sage Publications
Taschenbuch
ISBN: 978-0-8039-7075-5
Erschienen am 01.04.2001
Sprache: Englisch
Format: 229 mm [H] x 152 mm [B] x 11 mm [T]
Gewicht: 293 Gramm
Umfang: 196 Seiten

Preis: 91,50 €
keine Versandkosten (Inland)


Dieser Titel wird erst bei Bestellung gedruckt. Eintreffen bei uns daher ca. am 1. November.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

91,50 €
merken
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis
Biografische Anmerkung

Organized so that the reader moves from the simplest type of design to more complex ones, the authors introduce five different kinds of ANOVA techniques and explain which design/analysis is appropriate to answer specific questions.



Introduction
The Need for Analysis of Variance (ANOVA)
Means, Variances, Sums of Squares and Degrees of Freedom
Independent Group ANOVAs
One-Factor Independent Groups ANOVA
Multiple Comparisons: Independent Groups t-Tests
Two-Factor Independent Groups ANOVA
Repeated Measures ANOVAs
One-Factor Repeated Measures ANOVA
Multiple Comparisons: Dependent Measures t-Tests
Two-Factor Mixed Measures ANOVA
Two-Factor Repeated Measures ANOVA
Overview and Final Thoughts
Some Tips for Tests on ANOVA
Every Day Benefits of a Feel for Statistics and for Evaluating Data



Dr J. Rick Turner is President, Turner Consulting & Communications LLC, and Adjunct Professor of Pharmacy Practice at Campbell University College of Pharmacy & Health Sciences. He is an experimental research scientist and clinical trialist, with particular interests in the cardiac and cardiovascular safety of noncardiovascular drugs and the development and use of drugs for hypertension and type 2 diabetes mellitus.
He has published 15 books and over 100 peer-reviewed papers. He is member of the Cardiac Safety Research Consortium's Executive Committee and a Fellow of the Society of Behavioral Medicine, the American Society of Hypertension, the American College of Cardiology, the European Society of Cardiology, and the American College of Clinical Pharmacology.